Literature DB >> 16533513

Novel two-parameter flow cytometry (MIL4/SSC followed by MIL4/CT7) allows for identification of five fractions of guinea pig leukocytes in peripheral blood and lymphoid organs.

Mari Takizawa1, Joe Chiba, Shinji Haga, Toshihiko Asano, Tsuyoshi Yamazaki, Naoki Yamamoto, Mitsuo Honda.   

Abstract

Though the guinea pig has been an extremely useful animal model for a variety of diseases, the tools necessary to undertake a full-scale immunological analysis of the guinea pig have been lacking. For instance, traditional two-parameter forward/side scatter (FSC/SSC) flow cytometry, though effective in human and other animal models, is unable to adequately identify the distinct fractions of guinea pig peripheral blood leukocytes (PBL). We introduce here a new flow cytometric technique (MIL4/SSC followed by MIL4/CT7) which redresses this lack by identifying and characterizing five distinct fractions of PBL: neutrophils, lymphocytes, monocytes, eosinophils plus basophils, and the novel MIL4(-)SSC(large)CT7(high) population. The MIL4(-)SSC(large)CT7(high) cells possess cytoplasmic inclusion bodies of variable size that were positive for periodic acid Schiff (PAS). Their cell surface stained positive for the helper/inducer lymphocyte markers, T cell markers, CD45, Thy-1, asialo GM1 and FcR, but negative for B cell markers, such as membrane-type IgM, CD8 and MHC class II. The novel flow cytometric technique also allowed us to establish that the five leukocyte fractions were found in PBL, splenocytes, thymocytes and lymph node cells. Cells which were positive for inclusion bodies comprised 16.6% of splenocytes, 9.9% of PBL and 4.3% of liver cells, but were comparatively rare in lymph node cells, thymocytes, and BM cells. The novel flow cytometric technique introduced here will allow a better understanding of the response of each type of guinea pig leukocyte and thereby shed light on the diseases with which they are associated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533513     DOI: 10.1016/j.jim.2006.01.010

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  9 in total

1.  Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Authors:  Shaobin Shang; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Marcela Henao-Tamayo; Laurel Hascall-Dove; David Ackart; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Vaccine       Date:  2012-01-11       Impact factor: 3.641

2.  An optimized five-color/seven-parameter flow cytometry panel for immunophenotyping guinea pig peripheral blood lymphocytes.

Authors:  John V Stokes; Anna E Crawford; Claire E Cross; Anne-Marie L Ross; Jamie D Walker; Bridget V Willeford; Andrea S Varela-Stokes
Journal:  J Immunol Methods       Date:  2019-11-01       Impact factor: 2.303

3.  Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.

Authors:  Diane J Ordway; Crystal A Shanley; Megan L Caraway; Eileen A Orme; Daniel S Bucy; Laurel Hascall-Dove; Marcela Henao-Tamayo; Marisa R Harton; Shaobin Shang; David Ackart; Susan L Kraft; Anne J Lenaerts; Randall J Basaraba; Ian M Orme
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

4.  Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.

Authors:  Diane Ordway; Marcela Henao-Tamayo; Crystal Shanley; Erin E Smith; Gopinath Palanisamy; Baolin Wang; Randall J Basaraba; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2008-05-28

5.  Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity.

Authors:  Brendan K Podell; David F Ackart; Andres Obregon-Henao; Sarah P Eck; Marcela Henao-Tamayo; Michael Richardson; Ian M Orme; Diane J Ordway; Randall J Basaraba
Journal:  Am J Pathol       Date:  2014-01-31       Impact factor: 4.307

Review 6.  Using guinea pigs in studies relevant to asthma and COPD.

Authors:  Brendan J Canning; Yangling Chou
Journal:  Pulm Pharmacol Ther       Date:  2008-02-02       Impact factor: 3.410

Review 7.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 8.  The guinea pig model for tick-borne spotted fever rickettsioses: A second look.

Authors:  John V Stokes; David H Walker; Andrea S Varela-Stokes
Journal:  Ticks Tick Borne Dis       Date:  2020-08-07       Impact factor: 3.744

9.  Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.

Authors:  Christine A Bricault; James M Kovacs; Alexander Badamchi-Zadeh; Krisha McKee; Jennifer L Shields; Bronwyn M Gunn; George H Neubauer; Fadi Ghantous; Julia Jennings; Lindsey Gillis; James Perry; Joseph P Nkolola; Galit Alter; Bing Chen; Kathryn E Stephenson; Nicole Doria-Rose; John R Mascola; Michael S Seaman; Dan H Barouch
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.